Wexford Capital’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$433K	Buy	+8,906	New	+$433K	0.12%	114
2021 Q1	–	Sell	-300	Closed	-$46K	–	234
2020 Q4	$46K	Buy	+300	New	+$46K	0.01%	178